tiprankstipranks
NeuroOne Medical Technologies (NMTC)
NASDAQ:NMTC
US Market
NMTC
NeuroOne Medical Technologies
RESEARCH TOOLSreports
Want to see NMTC full AI Analyst Report?

NeuroOne Medical Technologies (NMTC) Ratios

195 Followers

NeuroOne Medical Technologies Ratios

NMTC's free cash flow for Q2 2026 was $0.54. For the 2026 fiscal year, NMTC's free cash flow was decreased by $ and operating cash flow was $-0.88. See a summary of the company’s cash flow.
Ratios
TTM
Sep 25Sep 24Sep 23Sep 22
Liquidity Ratios
Current Ratio
 4.37 4.44 2.09 4.08 3.93
Quick Ratio
 3.26 3.47 0.90 3.12 3.70
Cash Ratio
 1.66 2.85 0.66 2.97 2.63
Solvency Ratio
 -2.56 -0.90 -2.65 -6.31 -3.07
Operating Cash Flow Ratio
 -4.40 -1.23 -4.98 -7.19 -2.43
Short-Term Operating Cash Flow Coverage
 -64.86 0.00 0.00 0.00 0.00
Net Current Asset Value
$ 4.89M$ 6.51M$ 83.00K$ 5.47M$ 8.96M
Leverage Ratios
Debt-to-Assets Ratio
 0.03 0.02 0.05 0.02 0.02
Debt-to-Equity Ratio
 0.04 0.04 0.32 0.03 0.02
Debt-to-Capital Ratio
 0.04 0.04 0.24 0.03 0.02
Long-Term Debt-to-Capital Ratio
 0.00 0.00 0.00 0.00 0.00
Financial Leverage Ratio
 1.46 1.53 6.53 1.30 1.34
Debt Service Coverage Ratio
 31.71 -9.01 -51.72 0.00 0.00
Interest Coverage Ratio
 21.76 -12.65 -51.91 0.00 0.00
Debt to Market Cap
 <0.01 0.00 0.00 0.00 0.00
Interest Debt Per Share
 -0.01 0.09 0.02 0.01 0.01
Net Debt to EBITDA
 0.39 2.09 0.10 0.44 0.80
Profitability Margins
Gross Profit Margin
54.50%67.30%31.27%23.38%-41.36%
EBIT Margin
-71.18%-27.04%-350.10%-612.32%-5860.15%
EBITDA Margin
-68.54%-24.88%-342.96%-602.12%-5790.85%
Operating Profit Margin
-72.69%-34.94%-344.26%-612.32%-5860.15%
Pretax Profit Margin
-68.34%-29.80%-356.74%-607.42%-5841.95%
Net Profit Margin
-68.34%-29.80%-356.74%-607.42%-5841.95%
Continuous Operations Profit Margin
-68.34%-29.80%-356.74%-607.42%-5841.95%
Net Income Per EBT
100.00%100.00%100.00%100.00%100.00%
EBT Per EBIT
94.03%85.30%103.62%99.20%99.69%
Return on Assets (ROA)
-84.47%-33.43%-229.39%-146.46%-77.98%
Return on Equity (ROE)
-98.33%-50.98%-1498.53%-189.77%-104.12%
Return on Capital Employed (ROCE)
-114.42%-49.83%-376.57%-189.62%-103.16%
Return on Invested Capital (ROIC)
-112.33%-49.11%-368.88%-185.82%-102.28%
Return on Tangible Assets
-84.84%-33.57%-232.30%-148.10%-78.67%
Earnings Yield
-21.34%-10.11%-46.49%-73.50%-36.98%
Efficiency Ratios
Receivables Turnover
 4.01 9.56 19.55 0.00 5.15
Payables Turnover
 4.73 3.92 2.31 2.18 0.26
Inventory Turnover
 2.37 1.78 0.90 0.87 0.34
Fixed Asset Turnover
 22.75 23.52 5.14 2.81 0.32
Asset Turnover
 1.24 1.12 0.64 0.24 0.01
Working Capital Turnover Ratio
 1.56 2.34 0.87 0.27 0.02
Cash Conversion Cycle
 168.06 150.39 265.65 254.14 -265.71
Days of Sales Outstanding
 91.11 38.16 18.67 0.00 70.87
Days of Inventory Outstanding
 154.04 205.44 405.27 421.31 1.06K
Days of Payables Outstanding
 77.09 93.21 158.28 167.16 1.40K
Operating Cycle
 245.16 243.60 423.94 421.31 1.13K
Cash Flow Ratios
Operating Cash Flow Per Share
 -0.88 -0.42 -0.41 -0.71 -0.47
Free Cash Flow Per Share
 -0.90 -0.44 -0.42 -0.73 -0.49
CapEx Per Share
 0.02 0.01 <0.01 0.02 0.02
Free Cash Flow to Operating Cash Flow
 1.02 1.03 1.01 1.03 1.04
Dividend Paid and CapEx Coverage Ratio
 -55.71 -34.71 -91.61 -33.55 -27.32
Capital Expenditure Coverage Ratio
 -55.71 -34.71 -91.61 -33.55 -27.32
Operating Cash Flow Coverage Ratio
 -35.92 -10.63 -42.33 -69.89 -37.06
Operating Cash Flow to Sales Ratio
 -0.76 -0.23 -3.19 -6.60 -43.93
Free Cash Flow Yield
-23.79%-8.18%-42.02%-82.25%-28.83%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
 -4.69 -9.89 -2.15 -1.36 -2.70
Price-to-Sales (P/S) Ratio
 3.27 2.95 7.67 8.26 157.96
Price-to-Book (P/B) Ratio
 5.79 5.04 32.23 2.58 2.82
Price-to-Free Cash Flow (P/FCF) Ratio
 -4.20 -12.22 -2.38 -1.22 -3.47
Price-to-Operating Cash Flow Ratio
 -4.19 -12.57 -2.41 -1.25 -3.60
Price-to-Earnings Growth (PEG) Ratio
 0.05 0.12 0.07 -0.43 0.08
Price-to-Fair Value
 5.79 5.04 32.23 2.58 2.82
Enterprise Value Multiple
 -4.38 -9.76 -2.14 -0.94 -1.92
Enterprise Value
 29.21M 29.37M 25.29M 11.00M 19.08M
EV to EBITDA
 -4.38 -9.76 -2.14 -0.94 -1.92
EV to Sales
 3.00 2.43 7.33 5.63 111.47
EV to Free Cash Flow
 -3.86 -10.06 -2.27 -0.83 -2.45
EV to Operating Cash Flow
 -3.93 -10.35 -2.30 -0.85 -2.54
Tangible Book Value Per Share
 0.63 1.05 0.03 0.34 0.59
Shareholders’ Equity Per Share
 0.64 1.06 0.03 0.34 0.60
Tax and Other Ratios
Effective Tax Rate
 0.00 0.00 0.00 0.00 0.00
Revenue Per Share
 1.15 1.81 0.13 0.11 0.01
Net Income Per Share
 -0.79 -0.54 -0.46 -0.65 -0.63
Tax Burden
 1.00 1.00 1.00 1.00 1.00
Interest Burden
 0.96 1.10 1.02 0.99 1.00
Research & Development to Revenue
 0.53 0.41 1.47 3.55 28.80
SG&A to Revenue
 0.74 0.61 2.29 3.46 39.19
Stock-Based Compensation to Revenue
 0.11 0.10 0.39 0.57 5.53
Income Quality
 1.12 0.79 0.89 1.09 0.75
Currency in USD